AbbVie (ABBV) announced submission of a Biologics License Application or BLA to the U.S. Food and Drug Administration for accelerated ...
The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a ...
The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia,  the FDA announced Thursday.
Just as it began to seem that the battle against pseudoscience in medicine was being lost, a federal appeals court in San ...
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. In a new ...
The panel agreed with the FDA that the treatment in which a patient's tissue is processed doesn't fall under the same ...
In September 2024, the U.S. Food and Drug Administration (FDA) issued three guidance documents to support different clinical ...
The FDA has determined that the monoclonal antibody pemivibart (Pemgarda) is likely to be effective against currently ...